Pamela Esposito - Net Worth and Insider Trading
Pamela Esposito Net Worth
The estimated net worth of Pamela Esposito is at least $3 Million dollars as of 2024-12-26. Pamela Esposito is the Chief Business Officer of Replimune Group Inc and owns about 263,436 shares of Replimune Group Inc (REPL) stock worth over $3 Million. Pamela Esposito is also the Director of Kymera Therapeutics Inc and owns about 0 shares of Kymera Therapeutics Inc (KYMR) stock worth over $0. Details can be seen in Pamela Esposito's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pamela Esposito has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pamela Esposito
Pamela Esposito Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pamela Esposito owns 2 companies in total, including Replimune Group Inc (REPL) , and Kymera Therapeutics Inc (KYMR) .
Click here to see the complete history of Pamela Esposito’s form 4 insider trades.
Insider Ownership Summary of Pamela Esposito
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REPL | Replimune Group Inc | 2023-09-12 | Chief Business Officer |
| KYMR | Kymera Therapeutics Inc | 2024-12-02 | director |
Pamela Esposito Latest Holdings Summary
Pamela Esposito currently owns a total of 2 stocks. Among these stocks, Pamela Esposito owns 263,436 shares of Replimune Group Inc (REPL) as of September 12, 2023, with a value of $3 Million and a weighting of 100%. Pamela Esposito also owns 0 shares of Kymera Therapeutics Inc (KYMR) as of December 2, 2024, with a value of $0 and a weighting of 0%.
Latest Holdings of Pamela Esposito
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2023-09-12 | 263,436 | 12.94 | 3,408,862 |
| KYMR | Kymera Therapeutics Inc | 2024-12-02 | 0 | 41.79 | 0 |
Holding Weightings of Pamela Esposito
Pamela Esposito Form 4 Trading Tracker
According to the SEC Form 4 filings, Pamela Esposito has made a total of 14 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Replimune Group Inc is the sale of 5,658 shares on September 12, 2023, which brought Pamela Esposito around $113,217.
According to the SEC Form 4 filings, Pamela Esposito has made a total of 2 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 2,500 shares on December 2, 2024, which brought Pamela Esposito around $122,500.
Insider Trading History of Pamela Esposito
- 1
Pamela Esposito Trading Performance
Pamela Esposito Ownership Network
Pamela Esposito Owned Company Details
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Pamela Esposito is the Chief Business Officer of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Commercial Officer Sushil Patel , Chief Commercial Officer Christopher Sarchi , and Chief Medical Officer Konstantinos Xynos .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Pamela Esposito made 4 insider transaction in Replimune Group Inc (REPL) with a net sale of 45,658. Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 36,807 shares made by Konstantinos Xynos , a net sale of 12,680 shares made by Christopher Sarchi , and a net sale of 30,194 shares made by Sushil Patel .
In summary, during the past 3 months, insiders sold 22,453 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 22,453 shares. During the past 18 months, 203,582 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,582 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
Pamela Esposito Mailing Address
Above is the net worth, insider trading, and ownership report for Pamela Esposito. You might contact Pamela Esposito via mailing address: C/o Replimune Group, Inc., 18 Commerce Way, Woburn Ma 01801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
